{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:27:39Z","timestamp":1788460059339,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s40272-025-00690-w","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T10:45:49Z","timestamp":1744281949000},"page":"439-448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk Factors for Nephrotoxicity Among Neonates Receiving Vancomycin: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"27","author":[{"given":"Yuan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"690_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042052","author":"WC Kan","year":"2022","unstructured":"Kan WC, Chen YC, Wu VC, Shiao CC. Vancomycin-associated acute kidney injury: a narrative review from pathophysiology to clinical application. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23042052.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"690_CR2","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.ekir.2021.04.035","volume":"6","author":"N Tantranont","year":"2021","unstructured":"Tantranont N, Luque Y, Hsiao M, Haute C, Gaber L, Barrios R, et al. Vancomycin-associated tubular casts and vancomycin nephrotoxicity. Kidney Int Rep. 2021;6(7):1912\u201322. https:\/\/doi.org\/10.1016\/j.ekir.2021.04.035.","journal-title":"Kidney Int Rep."},{"issue":"12","key":"690_CR3","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.2215\/CJN.05190514","volume":"9","author":"JB Carmody","year":"2014","unstructured":"Carmody JB, Swanson JR, Rhone ET, Charlton JR. Recognition and reporting of AKI in very low birth weight infants. Clin J Am Soc Nephrol. 2014;9(12):2036\u201343. https:\/\/doi.org\/10.2215\/CJN.05190514.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"690_CR4","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1128\/AAC.48.4.1159-1167.2004","volume":"48","author":"T Kimura","year":"2004","unstructured":"Kimura T, Sunakawa K, Matsuura N, Kubo H, Shimada S, Yago K. Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates. Antimicrob Agents Chemother. 2004;48(4):1159\u201367. https:\/\/doi.org\/10.1128\/AAC.48.4.1159-1167.2004.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"690_CR5","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s10096-018-3277-8","volume":"37","author":"A Smits","year":"2018","unstructured":"Smits A, Pauwels S, Oyaert M, Peersman N, Spriet I, Saegeman V, et al. Factors impacting unbound vancomycin concentrations in neonates and young infants. Eur J Clin Microbiol Infect Dis. 2018;37(8):1503\u201310. https:\/\/doi.org\/10.1007\/s10096-018-3277-8.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"690_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S2352-4642(17)30069-X","volume":"1","author":"JG Jetton","year":"2017","unstructured":"Jetton JG, Boohaker LJ, Sethi SK, Wazir S, Rohatgi S, Soranno DE, et al. Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study. Lancet Child Adolesc Health. 2017;1(3):184\u201394. https:\/\/doi.org\/10.1016\/S2352-4642(17)30069-X.","journal-title":"Lancet Child Adolesc Health."},{"issue":"2","key":"690_CR7","doi-asserted-by":"publisher","first-page":"182e1","DOI":"10.1016\/j.amjmed.2009.05.031","volume":"123","author":"KA Hazlewood","year":"2010","unstructured":"Hazlewood KA, Brouse SD, Pitcher WD, Hall RG. Vancomycin-associated nephrotoxicity: grave concern or death by character assassination? Am J Med. 2010;123(2):182e1-187. https:\/\/doi.org\/10.1016\/j.amjmed.2009.05.031.","journal-title":"Am J Med"},{"issue":"5","key":"690_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jiph.2022.04.007","volume":"15","author":"JS Al-Maqbali","year":"2022","unstructured":"Al-Maqbali JS, Shukri ZA, Sabahi NA, Al-Riyami I, Al Alawi AM. Vancomycin therapeutic drug monitoring (TDM) and Its association with clinical outcomes: a retrospective cohort. J Infect Public Health. 2022;15(5):589\u201393. https:\/\/doi.org\/10.1016\/j.jiph.2022.04.007.","journal-title":"J Infect Public Health"},{"issue":"10","key":"690_CR9","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/jac\/dkaa184","volume":"75","author":"I Bellos","year":"2020","unstructured":"Bellos I, Daskalakis G, Pergialiotis V. Relationship of vancomycin trough levels with acute kidney injury risk: an exposure-toxicity meta-analysis. J Antimicrob Chemother. 2020;75(10):2725\u201334. https:\/\/doi.org\/10.1093\/jac\/dkaa184.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"690_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40262-019-00813-w","volume":"59","author":"SJF Hartman","year":"2020","unstructured":"Hartman SJF, Bruggemann RJ, Orriens L, Dia N, Schreuder MF, de Wildt SN. Pharmacokinetics and target attainment of antibiotics in critically ill children: a systematic review of current literature. Clin Pharmacokinet. 2020;59(2):173\u2013205. https:\/\/doi.org\/10.1007\/s40262-019-00813-w.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"690_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12887-017-0777-0","volume":"17","author":"V Bhargava","year":"2017","unstructured":"Bhargava V, Malloy M, Fonseca R. The association between vancomycin trough concentrations and acute kidney injury in the neonatal intensive care unit. BMC Pediatr. 2017;17(1):50. https:\/\/doi.org\/10.1186\/s12887-017-0777-0.","journal-title":"BMC Pediatr"},{"issue":"1","key":"690_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/ejhpharm-2019-002181","volume":"29","author":"TH Dawoud","year":"2022","unstructured":"Dawoud TH, Khan N, Afzal U, Varghese N, Rahmani A, Abu-Sa\u2019da O. Assessment of initial vancomycin trough levels and risk factors of vancomycin-induced nephrotoxicity in neonates. Eur J Hosp Pharm. 2022;29(1):44\u20139. https:\/\/doi.org\/10.1136\/ejhpharm-2019-002181.","journal-title":"Eur J Hosp Pharm"},{"issue":"4","key":"690_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106958","volume":"62","author":"E Chung","year":"2023","unstructured":"Chung E, Seto W. Association between vancomycin therapeutic drug monitoring and clinical outcomes in treating neonatal sepsis. Int J Antimicrob Agents. 2023;62(4): 106958. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106958.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"690_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41372-019-0519-2","volume":"40","author":"I Viel-Th\u00e9riault","year":"2020","unstructured":"Viel-Th\u00e9riault I, Martin B, Thompson-Desormeaux F, Blackburn J, Moussa A, Autmizguine J. Vancomycin drug monitoring in infants with CoNS sepsis-target attainment, microbiological response and nephrotoxicity. J Perinatol. 2020;40(1):97\u2013104. https:\/\/doi.org\/10.1038\/s41372-019-0519-2.","journal-title":"J Perinatol"},{"issue":"6","key":"690_CR15","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1248\/bpb.b23-00013","volume":"46","author":"T Miyai","year":"2023","unstructured":"Miyai T, Takekuma Y, Kashiwagi H, Sato Y, Nashimoto S, Sugawara M, et al. Risk factor analysis of vancomycin-induced nephrotoxicity in paediatric patients aged 0\u20131 year using japanese medical database. Biol Pharm Bull. 2023;46(6):817\u201323. https:\/\/doi.org\/10.1248\/bpb.b23-00013.","journal-title":"Biol Pharm Bull"},{"issue":"372","key":"690_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29(372): n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"issue":"12","key":"690_CR17","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.2215\/CJN.05920616","volume":"11","author":"A Sinha Ray","year":"2016","unstructured":"Sinha Ray A, Haikal A, Hammoud KA, Yu ASL. Vancomycin and the risk of aki: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2016;11(12):2132\u201340. https:\/\/doi.org\/10.2215\/CJN.05920616.","journal-title":"Clin J Am Soc Nephrol"},{"key":"690_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.666507","volume":"9","author":"Q Hu","year":"2021","unstructured":"Hu Q, Li SJ, Chen QL, Chen H, Li Q, Wang M. risk factors for acute kidney injury in critically ill neonates: a systematic review and meta-analysis. Front Pediatr. 2021;9: 666507. https:\/\/doi.org\/10.3389\/fped.2021.666507.","journal-title":"Front Pediatr"},{"key":"690_CR19","unstructured":"Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2021 May 3, 2021; Available from: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"issue":"4","key":"690_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"690_CR21","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.fertnstert.2023.02.018","volume":"119","author":"M Erden","year":"2023","unstructured":"Erden M, Uyanik E, Polat M, Ozbek IY, Yarali H, Mumusoglu S. The effect of < \/=6 cm sized noncavity-distorting intramural fibroids on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertil Steril. 2023;119(6):996\u20131007. https:\/\/doi.org\/10.1016\/j.fertnstert.2023.02.018.","journal-title":"Fertil Steril"},{"issue":"4","key":"690_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","volume":"171","author":"American Thoracic S, Infectious Diseases Society of A","year":"2005","unstructured":"American Thoracic S, Infectious Diseases Society of A. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388\u2013416. https:\/\/doi.org\/10.1164\/rccm.200405-644ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"690_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.pedneo.2021.11.010","volume":"63","author":"Q Chen","year":"2022","unstructured":"Chen Q, Wan J, Shen W, Lin W, Lin X, Huang Z, et al. Optimal exposure targets for vancomycin in the treatment of neonatal coagulase-negative Staphylococcus infection: a retrospective study based on electronic medical records. Pediatr Neonatol. 2022;63(3):247\u201354. https:\/\/doi.org\/10.1016\/j.pedneo.2021.11.010.","journal-title":"Pediatr Neonatol"},{"issue":"3","key":"690_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106300","volume":"57","author":"Z Tang","year":"2021","unstructured":"Tang Z, Guan J, Li J, Yu Y, Qian M, Cao J, et al. Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing. Int J Antimicrob Agents. 2021;57(3): 106300. https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106300.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"690_CR25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12887-023-04085-z","volume":"23","author":"BS Shin","year":"2023","unstructured":"Shin BS, Shin SH, Park SG, Kim EK, Kim HS. Factors associated with acute kidney injury among preterm infants administered vancomycin: a retrospective cohort study. BMC Pediatr. 2023;23(1):296. https:\/\/doi.org\/10.1186\/s12887-023-04085-z.","journal-title":"BMC Pediatr"},{"issue":"1","key":"690_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12882-020-1704-4","volume":"21","author":"X Qin","year":"2020","unstructured":"Qin X, Tsoi MF, Zhao X, Zhang L, Qi Z, Cheung BMY. Vancomycin-associated acute kidney injury in Hong Kong in 2012\u20132016. BMC Nephrol. 2020;21(1):41. https:\/\/doi.org\/10.1186\/s12882-020-1704-4.","journal-title":"BMC Nephrol"},{"issue":"6","key":"690_CR27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.5863\/1551-6776-25.6.521","volume":"25","author":"JW Bartlett","year":"2020","unstructured":"Bartlett JW, Gillon J, Hale J, Jimenez-Truque N, Banerjee R. Incidence of acute kidney injury among infants in the neonatal intensive care unit receiving vancomycin with either piperacillin\/tazobactam or cefepime. J Pediatr Pharmacol Ther. 2020;25(6):521\u20137. https:\/\/doi.org\/10.5863\/1551-6776-25.6.521.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"01","key":"690_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5428\/pcar20160109","volume":"16","author":"Z Li","year":"2016","unstructured":"Li Z, Xu F, Hu W, Xiao Z, Liu H, Li J, et al. Comparison of the nephrotoxicity of low trough concentration and high trough concentration of vancomycin in neonates. Phar Care Res. 2016;16(01):29\u201333.","journal-title":"Phar Care Res"},{"issue":"5","key":"690_CR29","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3969\/j.issn.1001-8689.2019.05.017","volume":"44","author":"X Tao","year":"2019","unstructured":"Tao X, Chen H, Pei B, Duan Y, Ma S. Effects of different trough concentrations of vancomycin on the renal function in neonates. Chin J Antibiot. 2019;44(5):628\u201331. https:\/\/doi.org\/10.3969\/j.issn.1001-8689.2019.05.017.","journal-title":"Chin J Antibiot"},{"key":"690_CR30","unstructured":"Chen Q, Wan J, Lin M. Correlation analysis between vancomycin trough concentrations and nephrotoxicity in neonates. J Mod Med Health. 2021;37(23)."},{"key":"690_CR31","unstructured":"Mahajan A, Marijic J. Hemodynamic management: anesthesia for congenital heart disease; 2008."},{"issue":"1","key":"690_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12887-019-1602-8","volume":"19","author":"TM Maloni","year":"2019","unstructured":"Maloni TM, Belucci TR, Malagutti SR, Furtado GHC. Describing vancomycin serum levels in pediatric intensive care unit (ICU) patients: are expected goals being met. BMC Pediatr. 2019;19(1):240. https:\/\/doi.org\/10.1186\/s12887-019-1602-8.","journal-title":"BMC Pediatr"},{"issue":"4","key":"690_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/NPM-15915022","volume":"8","author":"R Arcinue","year":"2015","unstructured":"Arcinue R, Kantak A, Elkhwad M. Acute kidney injury in ELBW infants (< 750 grams) and its associated risk factors. J Neonatal Perinatal Med. 2015;8(4):349\u201357. https:\/\/doi.org\/10.3233\/NPM-15915022.","journal-title":"J Neonatal Perinatal Med."},{"issue":"6","key":"690_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00228-019-02648-7","volume":"75","author":"T Hirai","year":"2019","unstructured":"Hirai T, Hanada K, Kanno A, Akashi M, Itoh T. Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment [published erratum appears in Eur J Clin Pharmacol 2019; 75: 867]. Eur J Clin Pharmacol. 2019;75(6):859\u201366. https:\/\/doi.org\/10.1007\/s00228-019-02648-7.","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl 2","key":"690_CR35","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1136\/ejhpharm-2020-002261","volume":"28","author":"Y Wang","year":"2021","unstructured":"Wang Y, Yang J, Zhan H, Zhang S, Deng Y. The potential risk factors of nephrotoxicity during vancomycin therapy in Chinese adult patients. Eur J Hosp Pharm. 2021;28(Suppl 2):e51\u20135. https:\/\/doi.org\/10.1136\/ejhpharm-2020-002261.","journal-title":"Eur J Hosp Pharm"},{"issue":"1","key":"690_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkz325","volume":"75","author":"KJ Downes","year":"2020","unstructured":"Downes KJ, Hayes M, Fitzgerald JC, Pais GM, Liu J, Zane NR, et al. Mechanisms of antimicrobial-induced nephrotoxicity in children. J Antimicrob Chemother. 2020;75(1):1\u201313. https:\/\/doi.org\/10.1093\/jac\/dkz325.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"690_CR37","doi-asserted-by":"publisher","first-page":"F236","DOI":"10.1136\/archdischild-2015-308459","volume":"101","author":"JE Constance","year":"2016","unstructured":"Constance JE, Balch AH, Stockmann C, Linakis MW, Korgenski EK, Roberts JK, et al. A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates. Arch Dis Child Fetal Neonatal Ed. 2016;101(3):F236\u201343. https:\/\/doi.org\/10.1136\/archdischild-2015-308459.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"12","key":"690_CR38","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology\u2013drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349(12):1157\u201367. https:\/\/doi.org\/10.1056\/NEJMra035092.","journal-title":"N Engl J Med"},{"issue":"1","key":"690_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1055\/s-0037-1604470","volume":"35","author":"N Srinivasan","year":"2018","unstructured":"Srinivasan N, Schwartz A, John E, Price R, Amin S. Acute kidney injury impairs postnatal renal adaptation and increases morbidity and mortality in very low-birth-weight infants. Am J Perinatol. 2018;35(1):39\u201347. https:\/\/doi.org\/10.1055\/s-0037-1604470.","journal-title":"Am J Perinatol"},{"issue":"2","key":"690_CR40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00467-008-1060-2","volume":"24","author":"DJ Askenazi","year":"2009","unstructured":"Askenazi DJ, Ambalavanan N, Goldstein SL. Acute kidney injury in critically ill newborns: what do we know? What do we need to learn? Pediatr Nephrol. 2009;24(2):265\u201374. https:\/\/doi.org\/10.1007\/s00467-008-1060-2.","journal-title":"Pediatr Nephrol"},{"key":"690_CR41","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-051220","author":"MC Starr","year":"2021","unstructured":"Starr MC, Charlton JR, Guillet R, Reidy K, Tipple TE, Jetton JG, et al. Advances in neonatal acute kidney injury. Pediatrics. 2021. https:\/\/doi.org\/10.1542\/peds.2021-051220.","journal-title":"Pediatrics"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-025-00690-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-025-00690-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-025-00690-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T14:57:59Z","timestamp":1750777079000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-025-00690-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["690"],"URL":"https:\/\/doi.org\/10.1007\/s40272-025-00690-w","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"12 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was supported by Lanzhou University Training Program of Innovation and Entrepreneurship for Undergraduates\u00a0(program\u00a0number:\u00a020240050124).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Wen Qiu contributed to the conceptualization and design of the study. Yuan Gao conducted the data analysis and wrote the review. Libin Pu searched the databases and collected the data. Tong Wu and Mengjie Wang extracted the data and performed the quality assessments. Chang Wang and Yinyin Guo validated the results and revised the article critically. All authors approved the final version of the manuscript to be submitted.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}